Psoriasis Current Events | Page 2

Psoriasis Current Events, Psoriasis News Articles.
Sort By: Most Viewed | Most Recent
Page 2 of 14 | 534 Results
Virtual communities may provide valuable support for psoriasis patients
Online support communities appear to offer both a valuable educational resource and a source of psychological and social support for individuals with psoriasis, according to a report in the January issue of Archives of Dermatology, one of the JAMA/Archives journals. (2009-01-19)

New study finds even a 'small' amount of psoriasis can negatively impact daily life
A study released Saturday in a special issue of the Journal of Investigative Dermatology (JID) finds that many adults with relatively small areas of psoriasis on their skin nevertheless report high levels of dissatisfaction with their current treatment, and also feel that psoriasis is a problem in their daily life. (2004-03-29)

Psoriasis patients have reduced access to efficient treatment method with age
A new study from Umeå University in Sweden shows that age plays a huge role when it comes to patients' access to psoriasis treatment. Researchers who have examined if patients of varying ages have the same access to the most efficient psoriasis treatment, found that an age increase of 30 years resulted in an average 65 percent reduction in likelihood of obtaining treatment with biologics. The study is described in an article published in the British Journal of Dermatology. (2016-01-19)

Wound healers cause skin disease
Dutch researcher Manon Franssen has shown that cells which heal the skin following an injury play an important role in the development of the skin disease psoriasis. In people with psoriasis, the skin peels much faster than normal so that it flakes and becomes inflamed. (2004-10-11)

Nearly 1 in 4 people with psoriasis may have undiagnosed psoriatic arthritis
New research shows one in four people with psoriasis may have undiagnosed psoriatic arthritis, in addition to the up to 2 million people already diagnosed with the disease. Also, there's a significant delay of diagnosis for psoriatic arthritis. (2011-10-12)

Psoriasis increases risk of diabetes, Penn study shows
Psoriasis is an independent risk for Type 2 Diabetes, according to a new study by researchers with the Perelman School of Medicine at the University of Pennsylvania, with the greatest risk seen in patients with severe psoriasis. Researchers estimate that an additional 115,500 people will develop diabetes each year due to the risk posed by psoriasis above and beyond conventional risk factors. The research is published in the latest issue of the Archives of Dermatology, a JAMA Network publication. (2012-06-18)

Gene variation is 'major genetic determinant of psoriasis'
A specific genetic region that has been increasingly identified as the strongest genetic link to psoriasis has an even more significant role in the chronic skin disease than has been suspected, University of Utah medical researchers show in a new study. (2009-08-27)

Three genes linked to psoriasis susceptibility identified on chromosome 17
Researchers using data gleaned from a tissue bank created by the National Psoriasis Foundation have identified three of the first genes associated with psoriasis. The finding, published in the December 2003 issue of the prestigious journal Nature Genetics, marks a significant advance in the understanding of psoriasis, an immune-mediated disease with both genetic and environmental triggers, and may lead to new treatments for the disease. (2003-11-09)

Psoriasis associated with cardiovascular disease and increased mortality
The skin disease psoriasis is associated with atherosclerosis (a buildup of plaque in the arteries) characterized by an increased prevalence of ischemic heart disease, cerebrovascular disease, peripheral artery disease and an increased risk of death, according to a report in the June issue of Archives of Dermatology, one of the JAMA/Archives journals. (2009-06-15)

Promising new target for treatment of psoriasis is safe, study shows
A protein known to play a significant role in the development of psoriasis can be prevented from functioning without posing a risk to patients, scientists at King's College London have found. The study confirmed that a group of inflammatory proteins called 'IL-36' play a significant role in the development of psoriasis and can, in theory, be blocked without posing a risk to patients. (2017-10-11)

A new direction for psoriasis research?
The National Psoriasis Foundation today hailed research that may eventually lead to additional therapies for treating psoriasis. A new Journal of Investigative Dermatology paper by Dr. Helen S. Young and colleagues at the University of Manchester (UK) provides the first evidence that there are alterations in a gene involving the development of the vascular system that may contribute to psoriasis susceptibility. (2004-01-03)

National Psoriasis Foundation launches online patient-centered research network
For the first time, people with psoriasis and psoriatic arthritis can contribute directly to the future of research into these chronic, systemic autoimmune diseases through the National Psoriasis Foundation's patient-centered research network called Citizen Pscientist. An online, interactive community, Citizen Pscientist allows people living with psoriatic disease to connect with researchers, share their data and get input from others in the community, and ultimately drive the direction of psoriatic disease research. Learn more at www.citizenpscientist.org. (2015-07-24)

NPF says FDA approval of new psoriasis drug signals new era of care
The National Psoriasis Foundation issued a statement today in support of the Food and Drug Administration's (FDA) approval of the first biologic drug to treat psoriasis. The FDA has approved Biogen's alefacept (brand name Amevive) to treat moderate to severe psoriasis. (2003-01-31)

High levels of estrogen during pregnancy associated with improvement in psoriasis
Increased levels of estrogen that occur during pregnancy may be associated with improvement in psoriasis, according to a study in the May issue of Archives of Dermatology, one of the JAMA/Archives journals. (2005-05-16)

UCI scientists identify lesion-healing mechanism in psoriasis
A UC Irvine-led study has revealed the underlying genetic factors that help repair skin lesions caused by psoriasis, which could engender new methods of controlling the lingering condition. (2014-10-27)

Most psoriasis patients taking immunosuppressants survive COVID-19
Patients with psoriasis who are taking drugs that affect their immune system have high rates of survival from COVID-19. According to the first findings from a global registry of psoriasis and COVID-19 patients, led by Guy's and St Thomas' clinicians, over 90% survive. (2020-10-20)

Hypertension, antihypertension medication, risk of psoriasis
Women with long-term high blood pressure appear to be at an increased risk for the skin condition psoriasis, and long-term use of beta (β)-blocker medication to treat hypertension may also increase the risk of psoriasis. (2014-07-02)

Psoriasis patients turn to alternative medicine when traditional treatments fail
A recent survey from the GW School of Medicine and Health Sciences found patients with psoriasis frequently use complementary or alternative therapies to treat their symptoms when traditional treatments fail. (2019-06-20)

Higher weight increases risk of psoriasis
The higher a person's BMI, the greater the chance of getting psoriasis. But researchers are still uncertain as to why. (2019-04-26)

Treatment has no sufficient effect in 1 of 5 psoriasis patients
A substantial part of people, one in five, undergoing systemic treatment for psoriasis (i.e. pills taken orally, injections or infusions) still have considerable problems with their disease. This is according to a study with 2,646 Swedish psoriasis patients conducted by researchers at Umeå University and the Swedish Institute for Health Economics, and recently published in the Journal of Dermatological Treatment. (2017-02-02)

National Psoriasis Foundation awards 12 psoriasis and psoriatic arthritis research fellowships
Twelve residents and medical students each received a one-year, $40,000 National Psoriasis Foundation fellowship to study psoriasis and psoriatic arthritis. The National Psoriasis Foundation Amgen Medical Dermatology Fellowships aims to increase the number of scientists studying and treating psoriatic diseases by encouraging promising doctors to dedicate their careers to psoriasis and psoriatic arthritis as physician researchers. (2013-07-02)

An agent used to treat psoriasis may be aimed at the wrong target
The antibody ustekinumab is being used successfully for the treatment of psoriasis since 2009. It inhibits the underlying inflammation by neutralizing certain messengers of the immune system. Researchers at the University of Zurich and the Center of Allergy and Environment in Munich have now shown that one of these messengers could actually be helpful in battling the disease. (2016-11-30)

The National Psoriasis Foundation announces new sources of help for researchers and physicians
The National Psoriasis Foundation today announced the granting of $220,000 to researchers studying the immunology and genetics of psoriasis; and the publication of Therapy of Moderate-to-Severe Psoriasis, a guide for medical professionals who treat the more than 1 million U.S. adults who have moderate-to-severe psoriasis. (2003-04-30)

UV-B treatment may improve psoriasis and vitamin D levels
Treatment with narrow-band UV-B rays may increase serum levels of vitamin D in the wintertime while clearing psoriasis, according to a report in the August issue of Archives of Dermatology, one of the JAMA/Archives journals. (2010-08-16)

Kids with psoriasis likely to be obese or overweight
The largest international study of physician-treated children with psoriasis shows children with the skin disease are about twice as likely to be overweight or obese than children who don't have the disease. And US children with psoriasis have much higher odds than psoriatic children in other countries of being obese or overweight. (2012-11-19)

Skin-disease patients show brain immunity to faces of disgust
People with psoriasis -- an often distressing dermatological condition that causes lesions and red scaly patches on the skin -- are less likely to react to looks of disgust by others than people without the condition, new research has found. (2009-08-27)

Features of the metabolic syndrome common in persons with psoriasis
Individuals with psoriasis have a high prevalence of the metabolic syndrome, according to a report posted online today that will appear in the April 2011 print issue of Archives of Dermatology, one of the JAMA/Archives journals. (2010-12-20)

National Psoriasis Foundation awards five Translational Research Grants
Five researchers each received a two-year, $200,000 grant from the National Psoriasis Foundation for their work to improve treatments for psoriasis and psoriatic arthritis, determine genetic risk factors and find new ways to manage psoriatic disease. (2015-06-03)

Scientists uncover new genetic variations linked to psoriasis
Two international teams of researchers have made significant gains in understanding the genetic basis of psoriasis, a chronic skin condition that can be debilitating in some patients. Their research, involving thousands of patients, is reported in two studies published this week in the advance online Nature Genetics. (2009-01-26)

Acitretin therapy may help reduce nail psoriasis
Low-dose acitretin (a drug used to treat skin psoriasis) therapy appears to reduce nail psoriasis symptoms, according to a report in the March issue of Archives of Dermatology, one of the JAMA/Archives journals. (2009-03-16)

Vigorous physical activity associated with reduced risk of psoriasis
A study of US women suggests that vigorous physical activity may be associated with a reduced risk of psoriasis, according to a report published online first by Archives of Dermatology, a JAMA Network publication. (2012-05-21)

Alefacept effective in treating patients with psoriasis
Patients with psoriasis treated with the drug alefacept experienced a reduction in severity of their skin disease, according to an article in the December issue of The Archives of Dermatology, one of the JAMA/Archives journals. (2003-12-15)

Benvitimod cream: a new topical treatment for plaque psoriasis
Psoriasis is a chronic inflammatory skin condition characterized by skin plaques and itching. Currently, the most common topical treatments for psoriasis are corticosteroids and vitamin D3 analogs. But these drugs have various side-effects. A recent phase III clinical trial of the novel non-steroidal compound benvitimod in China, published in Chinese Medical Journal, shows that it is safe and effective and could be a promising new topical treatment for psoriasis. (2021-01-19)

National Psoriasis Foundation awards $600,000 in Discovery Grants
The National Psoriasis Foundation awarded eight researchers each a one-year, $75,000 Discovery Grant to support the advancement of psoriatic disease research. By gaining a better understanding of the fundamentals of psoriatic disease -- what causes psoriasis and psoriatic arthritis and what happens in the body when these diseases are present -- scientists can work on better treatments and a cure. (2015-06-02)

Comparing coronary artery calcium scores in patients with psoriasis, diabetes
Assessing coronary artery calcium (CAC) is a measure of the severity of atherosclerosis (clogged arteries) and a cornerstone for screening for risk of future cardiac events. The inflammatory skin condition psoriasis has been associated with increased risk of cardiovascular disease. Type 2 diabetes is a high-risk disease associated with increased cardiovascular risk. (2016-08-24)

National Psoriasis Foundation awards $450,000 in research grants
Six of the top scientists studying psoriasis -- the most common autoimmune disease in the country, affecting 7.5 million Americans -- and psoriatic arthritis, an inflammatory joint and tendon disease affecting up to 30 percent of people with psoriasis, received National Psoriasis Foundation research grants totaling $450,000 for projects that aim to discover new treatments and a cure for these chronic diseases. (2013-06-04)

People with severe psoriasis nearly twice at risk for diabetes
An analysis of 27 studies linking psoriasis in 314,000 individuals with diabetes has found strong correlation between the scaly skin rash and the blood sugar disorder that predisposes patients to heart disease, say UC Davis researchers who led the review. (2012-10-15)

Depression puts psoriasis patients at significantly greater risk of psoriatic arthritis
Psoriasis is a lifelong disease that is associated with significant cosmetic and physical disability and puts patients at increased risk for many major medical disorders. A multidisciplinary team of researchers at the University of Calgary, Canada, have found that psoriasis patients who developed depression were at a 37 percent greater risk of subsequently developing psoriatic arthritis, compared with psoriasis patients who did not develop depression. Their findings are published in the Journal of Investigative Dermatology. (2017-02-22)

Experts turn to Web to combat distressing skin disease
People experiencing the skin disease psoriasis may get relief from their symptoms and the psychological distress they can cause through a new Web-based therapy program. (2009-03-23)

More severe psoriasis explains the higher costs of care for men
Men often suffer from more severe cases of psoriasis than women, which may explain why the cost of care for men is higher. This is the conclusion of researchers at Sweden's Umeå University in a new study. (2013-05-15)

Page 2 of 14 | 534 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.